Document is current
Any future updates will be listed below
-
Authors
Pang, Lizhi
Dunterman, Madeline http://orcid.org/0009-0009-5329-3314
Guo, Songlin
Khan, Fatima
Liu, Yang
Taefi, Erfan
Bahrami, Atousa
Geula, Changiz
Hsu, Wen-Hao
Horbinski, Craig
James, Charles David
Chen, Peiwen http://orcid.org/0000-0002-8129-9328
- License Information
-
More Information
Article History
Received: 6 September 2022
Accepted: 27 July 2023
First Online: 4 September 2023
Competing interests
: L.P. and P.C. are listed as inventors on a patent related to targeting the TFPI2–CD51–STAT6 signaling axis combining with or without anti-PD1 therapy. All other authors declare no competing interests.
